See also this year's filing and all EDGAR filings for this company.
PDF Report 0001344413_2014_Alexza_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001344413, Alexza Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 30,913,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 14,991,000 |
| 3 | remainder_Assets | 1,168,000 |
| 4 | LiabilitiesCurrent | 14,898,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,778,000 |
| 9 | ResearchAndDevelopmentExpense | 19,082,000 |
| 10 | remainder_Expenses | 52,620,000 |
| 11 | remainder_Revenues | 47,839,000 |
| 12 | remainder_NetIncome | 26,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 47,072,000 |
| 1 | Liabilities | 14,898,000 |
| 2 | Expenses | 87,480,000 |
| 3 | Revenues | 47,839,000 |
| 4 | StockholdersEquity | 32,174,000 |
| 5 | NetIncome | -39,615,000 |
| 6 | ComprehensiveNetIncome | -39,615,000 |
| 7 | BaseVar | 98,657,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.985 |
| 9 | EconomicCapitalRatio | 2.29 |
Edgar->Model Mapping
Feature Distribution
Change over Time
